LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
TRIB
Trinity Biotech plc
There isn't enough reported data to score TRIB yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
TRIB Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Weak |
TRIB's revenue, profitability, cash flow and balance sheet are all currently under pressure.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
TRIB PE Valuation
TRIB has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
TRIB Forward outlook
There aren't enough analyst estimates for TRIB to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the stronger earnings trend. Trailing diluted EPS is up 51% for LLY versus TRIB down 174%.
TRIB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$60.60 | +$21.54 |
| Q3 2025 | -$68.28 | -$0.42 |
| Q2 2025 | -$73.86 | +$6.60 |
| Q1 2025 | -$85.44 | -$2.88 |
| Q4 2024 | -$82.14 | +$14.16 |
| Q3 2024 | -$67.86 | +$46.44 |
| Q2 2024 | -$80.46 | +$42.54 |
| Q1 2024 | -$82.56 | +$113.04 |
TRIB is still losing money, but far less than before: $60.60 per share over the past year, against $195.60 at its worst in early 2023.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the stronger quarterly revenue trend. Revenue is up 39% for LLY versus down 30% for TRIB.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
TRIB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $11.1M | -30% |
| Q3 2025 | $14.2M | -6% |
| Q2 2025 | $11M | -31% |
| Q1 2025 | $7.6M | -48% |
| Q4 2024 | $15.9M | +18% |
| Q3 2024 | $15.2M | +3.2% |
| Q2 2024 | $15.8M | +14% |
| Q1 2024 | $14.7M | -0.8% |
TRIB's revenue has slid since its 2020 peak: $11M last quarter, down 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -27% | +46 points |
| Q3 2025 | -3.8% | +13 points |
| Q2 2025 | -28% | -2.2 points |
| Q1 2025 | -62% | -42 points |
| Q4 2024 | -73% | -47 points |
| Q3 2024 | -17% | +14 points |
| Q2 2024 | -26% | +81 points |
| Q1 2024 | -21% | +5.8 points |
TRIB's operating margin was −27% last quarter, up 46 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with TRIB at up 4.7%.
TRIB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.5M | -351% |
| Q3 2025 | -$77.1K | +$6.2M |
| Q2 2025 | -$1.7M | +$2.6M |
| Q1 2025 | -$3M | +$3.3M |
| Q4 2024 | $615K | +$2.5M |
| Q3 2024 | -$6.3M | -$1M |
| Q2 2024 | -$4.3M | +$715K |
| Q1 2024 | -$6.3M | -$2.9M |
TRIB has burned cash in most quarters: −$6M over the past year, against −$16M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over TRIB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
TRIB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -950 shares |
| 1 year | +31% | +148K shares |
| 3 years | +144% | +367K shares |
| 5 years | +249% | +443K shares |
| Available history | +266% | +451K shares |
TRIB has 620,900 diluted shares, up 31% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $270,000 |
| Q1 2024 | — |
TRIB hasn't bought back shares in the past year.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
TRIB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | 12.0x | High |
| Q4 2021 | 7.5x | High |
| Q3 2021 | 16.9x | High |
| Q2 2021 | 5.2x | High |
| Q1 2021 | 11.4x | High |
| Q4 2020 | 24.1x | High |
| Q3 2020 | 3.5x | Elevated |
| Q2 2020 | 6.5x | High |
TRIB's net debt is about 12 years of its operating earnings (EBITDA), up from 11 years a year ago.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
TRIB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.6 | Neutral |
| Stochastic | 10.5 | Oversold |
TRIB's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
TRIB PE vs Healthcare Sector
TRIB has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has stronger trend alignment. LLY is above 5 of 5 weekly averages versus TRIB above 0 of 3.
TRIB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.56 | 10% below |
| 20 week MA | $8.71 | 32% below |
| 50 week MA | $16.5 | 64% below |
TRIB is in a downtrend: it's below all three of its weekly moving averages, and 64% below its 50-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over TRIB on returns for 2026, with the stronger performance.
TRIB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $43.8 | $30.0 | -32% |
| 2026 YTD | $30.0 | $5.88 | -80% |
TRIB has finished every year since 2025 lower, and it's down 80% so far in 2026.